King Hussein Cancer Center — Amman

Public research footprint of King Hussein Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Metastatic Breast Cancer · Acute Lymphoblastic Leukemia Not Having Achieved Remission · Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Recently updated registry entries

NCT05894239 — A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo… (Recruiting)
NCT05653063 — ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical… (Active Not Recruiting)
NCT05296798 — A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at King Hussein Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.